Why #Injective ?
Regulated finance
▸ SEC-registered Transfer Agent
▸ Canary Staked $INJ ETF + 21Shares Injective ETF filings
▸ MiCA white paper in Europe
▸ Regulated #INJ futures
Real-world assets
▸ $1B+ in tokenized mortgage records
▸ Trade receivables being explored with POSCO International & LG CNS
Global liquidity
▸ USDC.inj as the canonical $USDC standard across #Cosmos & dYdX
▸ MultiVM: WASM + EVM
▸ INJ expanding into the Solana ecosystem
Builder pipeline
▸ Nova with Microsoft + Web3Labs
▸ AI infrastructure and iAgent
▸ Ongoing grants, hackathons and incubation programs
And this is only a snapshot of what Injective has been building.
Now compare that infrastructure with the valuations of other major L1s.
Some already command multi-billion-dollar market caps.
Injective is building toward a similar financial infrastructure thesis, but from a much smaller valuation base.
That creates a valuation gap worth paying attention to.
The more I look at what Injective is building, the harder it is to justify its current valuation relative to the scale of the infrastructure already being built.
Regulated finance
▸ SEC-registered Transfer Agent
▸ Canary Staked $INJ ETF + 21Shares Injective ETF filings
▸ MiCA white paper in Europe
▸ Regulated #INJ futures
Real-world assets
▸ $1B+ in tokenized mortgage records
▸ Trade receivables being explored with POSCO International & LG CNS
Global liquidity
▸ USDC.inj as the canonical $USDC standard across #Cosmos & dYdX
▸ MultiVM: WASM + EVM
▸ INJ expanding into the Solana ecosystem
Builder pipeline
▸ Nova with Microsoft + Web3Labs
▸ AI infrastructure and iAgent
▸ Ongoing grants, hackathons and incubation programs
And this is only a snapshot of what Injective has been building.
Now compare that infrastructure with the valuations of other major L1s.
Some already command multi-billion-dollar market caps.
Injective is building toward a similar financial infrastructure thesis, but from a much smaller valuation base.
That creates a valuation gap worth paying attention to.
The more I look at what Injective is building, the harder it is to justify its current valuation relative to the scale of the infrastructure already being built.
